| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.772 | 10.312 | 9.643 | - | 11.532 | - | - | - | 4.405 | 5.115 |
| Total Income - EUR | 10.702 | 10.315 | 10.664 | - | 11.532 | - | - | - | 4.405 | 5.284 |
| Total Expenses - EUR | 10.147 | 8.772 | 9.568 | - | 10.082 | - | - | - | 9.801 | 8.992 |
| Gross Profit/Loss - EUR | 555 | 1.543 | 1.097 | - | 1.450 | - | - | - | -5.396 | -3.708 |
| Net Profit/Loss - EUR | 234 | 1.234 | 776 | - | 1.104 | - | - | - | -5.396 | -3.708 |
| Employees | 0 | 0 | 0 | - | 0 | - | - | - | 0 | 0 |
Check the financial reports for the company - Anebtawi Pro Sanitas Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.378 | 5.053 | 3.728 | - | 1.204 | - | - | - | 36 | 36 |
| Current Assets | 4.368 | 4.607 | 6.495 | - | 12.750 | - | - | - | 3.855 | 420 |
| Inventories | 0 | 0 | 0 | - | 0 | - | - | - | 10 | 116 |
| Receivables | 3.498 | 3.613 | 3.140 | - | 3.650 | - | - | - | 3.185 | -416 |
| Cash | 870 | 993 | 3.355 | - | 9.100 | - | - | - | 659 | 720 |
| Shareholders Funds | 4.517 | 5.705 | 6.137 | - | 9.215 | - | - | - | 1.139 | -2.575 |
| Social Capital | 45 | 45 | 44 | - | 42 | - | - | - | 40 | 40 |
| Debts | 6.485 | 4.252 | 4.346 | - | 5.051 | - | - | - | 3.064 | 3.347 |
| Income in Advance | 0 | 0 | 0 | - | 0 | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Anebtawi Pro Sanitas Srl